GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Amgen AMGN · USD

Health Care · Biotechnology · US listing · 🇺🇸 United States

S&P 500Nasdaq-100Dow Jones

Compare

465.23

+1.04%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Amgen

Our reporting

Next results

2 Feb 2027

Due on 2 Feb 2027. Analysts expect earnings of 5.73 a share on revenue of $10.44bn.

Past results

Reported against what analysts expected

3 Nov 20264 Aug 202630 Apr 20263 Feb 20264 Nov 20255 Aug 2025
Earnings per share6.456.295.155.295.646.02
Forecast5.795.624.774.735.025.28
Revenue$10.37bn$10.05bn$8.62bn$9.87bn$9.56bn$9.17bn
Forecast$10.07bn$9.43bn$8.58bn$9.47bn$8.97bn$8.94bn

Key events

  1. 22 Nov 19992-for-1 share split
  2. 1 Mar 19992-for-1 share split
  3. 16 Aug 19952-for-1 share split
  4. 11 Sept 19913-for-1 share split
  5. 13 Aug 19902-for-1 share split
  6. 1 May 1987Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.